News|Articles|February 10, 2023
SCOPE 2023: Future Areas of Investment in Clinical Trials
Author(s)Andy Studna, Senior Editor
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how the clinical trials sector is evolving, specifically with increased investment in decentralized trials and recent technological advancements such as artificial intelligence and digital biomarkers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Real-World Evidence Can No Longer Wait Until After Approval
2
Three Tensions Transforming Clinical Operations Excellence
3
ACT Brief: Process Architecture Over Autonomous AI, Real-Time RWE Integration, and Building RWE Infrastructure
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5